Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure. Ann Med Res [Internet]. 2021 Oct. 20 [cited 2025 May 9];28(10):1824-9. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/3934